People: STAR Pharmaceutical Ltd (SRPT.SI)

SRPT.SI on Stock Exchange of Singapore

0.07SGD
18 Dec 2014
Price Change (% chg)

-- (--)
Prev Close
$0.07
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
67,129
52-wk High
$0.08
52-wk Low
$0.03

Search Stocks

Summary

Name Age Since Current Position

Zhi Bin Xu

2012 Executive Chairman of the Board

Yim Ling Chung

2012 Chief Financial Officer

Ling Yong Zhu

2012 General Manager

Yan Gu

2012 Executive Director

Chong Ming Hu

Finance Manager

Sey Liy Tan

2014 Company Secretary

Tak Tai Li

2009 Non-Executive Director

Poh Khoon Ng

45 2005 Non-Executive Independent Director

Manping Wu

2005 Non-Executive Independent Director

Michael Tan

Investor Relations Officer

Biographies

Name Description

Zhi Bin Xu

Mr. Xu Zhi Bin has been Executive Chairman of the Board of STAR Pharmaceutical Ltd since November 19, 2012. Mr. Xu Zhi Bin has over 16 years’ experience in the pharmaceutical industry specializing in sales and marketing. Between 2005 and 2012, he was the General Manager of Beijing Jiuzhou Jikang Pharmaceutical Co., Ltd., where he was responsible for overall strategic planning and direction of the company, including the day-to-day management, financial planning and budgeting, sales and marketing, product development and management, and long-term investment strategy of the company. Prior to that between 2000 and 2005, he was the Director of Sales of Hainan Tongyong Sanyang Pharmaceutical Co., Ltd., where he was responsible for all sales and marketing activities of the company. Between 1996 and 2000, he was the Sales Manager of Shenzhen Jianhua Pharmaceutical Co., Ltd. Mr. Xu graduated from the Capital University of Medical Sciences 1996 with a Bachelor’s Degree majoring in clinical medicine.

Yim Ling Chung

Ms. Chung Yim Ling has been Chief Financial Officer of STAR Pharmaceutical Ltd since October 15, 2012. Ms. Chung is responsible for overseeing the Group’s financial and administrative matters. Prior to joing the Group, she was a Vice President of Credit Suisse AG from March 2010 to May 2012, where she was responsible for providing wealth management services to clients. From October 2000 to March 2010, she was a Vice President (Private Banking) of DBS Bank (Hong Kong) Limited . From June 1997 to April 2000, she was the Finance and Administration Manager of Denton Wilde Sapte. She was a Finance Manager (Australia) of Banyan Systems Asia Pacific Inc from June 1995 to May 1997. She worked for Ernst & Young from July 1988 to August 1994.

Ling Yong Zhu

Mr. Zhu Ling Yong is General Manager of STAR Pharmaceutical Ltd since 2012. Mr. Zhu has over 25 years experience in the pharmaceutical industry and he is responsible for the overall management of the factory, including production, quality control. Between 2003 and 2012, he took various positions with Shan Xi Qian Yuan Pharmaceutical Co., Ltd. and his last position was Production and Quality Director. Prior to that, from 2001 to 2003, he was the Project Vice Director of Aurobindo Biological Pharmaceutical Co., Ltd. Mr. Zhu graduated from TaiYuan University of Science and Technology with a Bachelor degree in 1987.

Yan Gu

Mr. Gu Yan has been Executive Director of STAR Pharmaceutical Ltd since November 30, 2012. Mr. Gu Yan has over 14 years experience in the pharmaceutical industry. Between 2009 to 2012, Mr. Gu was the general manager of Beijing Ji Kang Li Tong Pharmaceutical Technology Co., Ltd, responsible for daily operation of the Company. Form 2005 to 2009, he was appointed the Director of Sales for Beijing Ji Kang Li Tong Pharmaceutical Technology Co., Ltd, Mr. Gu was responsible for marketing and sales activities, production investment, processing cooperation activities as well as in charge of new products research and development work of the company nationwide. Between 2003 to 2005 he was the sales manager for Kun Ming Pharmaceutical Group Sales Co., Ltd. From 1998 to 2003 he was the sales manager of Hai Nan Tong Yong San Yang Pharmaceutical Co., Ltd.

Chong Ming Hu

Mr. Hu Chong Ming is the Finance Manager of STAR Pharmaceutical Ltd. He has been with the Group since February 2001. He is responsible for assisting Financial Controller in the management of Group’s accounts and financial reporting. Prior to joining Group, he was a principal staff member at Anhui Province Foreign Economic and Trade Commission from 1987 to 1991. From 1991 to 2001, he was the finance manager at Anhui Province Medicine and Health Products Import and Export Co. Ltd. He majored in International Trade from Shanghai University of Foreign Trade. He obtained the China Professional Technical Qualification Certificate in Accounting, as well as a Western Accounting Course Completion Certificate from Montreal University, New Jersey, in 1997, and was awarded the Anhui Province Advanced Individual Award in Liquidation and Asset Management in 1995.

Sey Liy Tan

Tak Tai Li

Ms. Li Tak Tai Leada serves as Non-Executive Director of STAR Pharmaceutical Ltd since August 24, 2009. She is currently, and has been since December 2006, the Chief Financial Officer of China Precision Steel, Inc., a company that is engaged in high valueadd steel processing and listed on the Nasdaq Capital Market, where Ms Li is responsible for overseeing the financial, accounting and administrative matters of the Company. From December 2006 to August 2009, Ms. Li was part time investor relations consultant where she was responsible for the Company’s inves tor relat ions and corporate communication matters. Prior to that, between June 2004 to November 2006, Ms Li was Assistant to the Chairman of company, in charge of the Group’s Initial Public Offering on the SGX-ST and investor relations. From November 2003 to May 2004, Ms Li was an audit assistant at KPMG, Hong Kong, where she assisted her seniors in carrying out commercial due diligence of target companies located in the PRC. Prior to that, from January 2002 to September 2002, Ms Li was an Investment Analyst at Suez Asia Holdings (HK) Limited, where she assisted with the research work for various private equity deals. Ms Li holds a Bachelor of Commerce Degree with dual major in Accounting and Finance from the University of Melbourne in Australia and a Master of Science Degree in Accounting and Finance from the Napier University in the United Kingdom.

Poh Khoon Ng

Mr. Ng Poh Khoon, CPA, serves as Non-Executive Independent Director of STAR Pharmaceutical Ltd since September 27, 2005. He is currently the Director, Sales & Marketing of Passion Group, of which he heads the export division. Passion group is based in Longyan City, Fuijan Province, involves in design, production and sale of handicrafts, furniture and home furnishings. Prior to that, from November 2008 to December 2011, he is the Chief Financial Officer of Passion Holdings Limited, a listed company formerly quoted on main board of SGX-ST. From October 2004 to October 2008, Mr Ng was the Chief Financial Officer of the Sinoying group of companies, which is primarily engaged in the business of shipping and oil trading. He oversees the financial, accounting and taxation matters of the group’s operations in Singapore, the PRC and Hong Kong. He was also the deputy managing director of Sinoying Logistics Pte. Ltd., the shipping arm of the Sinoying Group and assisted in its daily operations during the same period. From 1995 to 1997, he was a senior in the Audit department of Moore Stephens Singapore, carrying out statutory audits. He joined an audit department of KPMG Singapore in 1997 as a senior and was subsequently promoted to a supervisor in 1998. In July 2000, he assumed the position of audit manager and his responsibilities included managing a department, managing portfolios of clients , managing initial public offerings, as well as business development activities. He is currently the independent director and audit committee’s chairman of Lottvision Limited, which is currently listed on the SGX-ST. Mr Ng holds a Diploma in Business Administration from the National Productivity Board, and is a Certified Public Accountant and a member of the Institute of Certified Public Accountants of Singapore and Singapore Institute of Directors. Mr Ng is also a fellow member of the Association of Chartered Certified Accountants, United Kingdom.

Manping Wu

Mr. Wu Manping serves as Non-Executive Independent Director of Star Pharmaceutical Ltd since September 27, 2005. He is currently a professor at Fudan University. Mr Wu was on the standing committee of the Chinese Pharmaceutical Association and the Shanghai Biochemistry and Molecular Biology Society. He was also deputy chairman of the standing committee Shanghai Pharmaceutical Association. Prior to joining Fudan University, he was a pharmacist at Anhui Province Huaning County Hospital from 1968 to 1978. From 1981 to 1999, he was with Shanghai Medical University where he held various appointments, including professor and chairman of the Biochemistry depar tment and subsequently dean of the School of Pharmacy. He holds a degree in pharmacy from Shanghai No.1 Medical College and a Masters of Biochemistry from Shanghai Medical University.

Michael Tan

Basic Compensation

Options Compensation

Search Stocks